A basic study on molecular hydrogen (H2) inhalation in acute cerebral ischemia patients for safety check with physiological parameters and measurement of blood H2 level

Abstract

BackgroundIn animal experiments, use of molecular hydrogen ( H2) has been regarded as quite safe and effective, showing benefits in multiple pathological conditions such as ischemia-reperfusion injury of the brain, heart, kidney and transplanted tissues, traumatic and surgical injury of the brain and spinal cord, inflammation of intestine and lung , degenerative striatonigral tissue and also in many other situations. However, since cerebral ischemia patients are in old age group, the safety information needs to be confirmed. For the feasibility of H2 treatment in these patients, delivery of H2 by inhalation method needs to be checked for consistency.MethodsHydrogen concentration (HC) in the arterial and venous blood was measured by gas chromatography on 3 patients, before, during and after 4% (case 1) and 3% (case2,3) H2 gas inhalation with simultaneous monitoring of physiological parameters. For a consistency study, HC in the venous blood of 10 patients were obtained on multiple occasions at the end of 30-min H2 inhalation treatment.ResultsThe HC gradually reached a plateau level in 20 min after H2 inhalation in the blood, which was equivalent to the level reported by animal experiments. The HC rapidly decreased to 10% of the plateau level in about 6 min and 18 min in arterial and venous blood, respectively after H2 inhalation was discontinued. Physiological parameters on these 3 patients were essentially unchanged by use of hydrogen. The consistency study of 10 patients showed the HC at the end of 30-min inhalation treatment was quite variable but the inconsistency improved with more attention and encouragement.ConclusionH2 inhalation of at least 3% concentration for 30 min delivered enough HC, equivalent to the animal experiment levels, in the blood without compromising the safety. However, the consistency of H2 delivery by inhalation needs to be improved.

Hydrogen Gas Does Not Ameliorate Renal Ischemia Reperfusion Injury in a Preclinical Model

“…The solubility of hydrogen in blood is less than water and decreases with increasing temperature. Furthermore, difficulty in achieving consistent and adequate blood concentrations when hydrogen has been administered as gas has been previously reported in human subjects (22). This is one possible explanation for the negative finding in this present study.…”

Non-pharmaceutical therapies for stroke: Mechanisms and clinical implications

“…Studies using other rat models confirmed the effects of hydrogen on the improvement of neurological function (Cai et al , 2008; Chen et al , 2010; Matchett et al , 2009). A recent clinical study treated 13 cerebral ischemia patients with hydrogen inhalation and showed that 3–4% hydrogen inhalation over 30 mins was feasible and safe in stroke patients (Ono et al , 2012). …”

The evolution of molecular hydrogen: a noteworthy potential therapy with clinical significance

“…Because hydrogen gas has no foreign smell, it can easily be inhaled into the body [21]. Although some reports have shown that complications involving facemasks and unattended patients, specifically neurologically impaired patients, may cause inconsistencies with inhalation.…”